Join the CRM Legacy Meeting for a comprehensive examination of Cardio-Renal-Metabolic health, focusing on the Empagliflozin-Linagliptin combination. Our expert panel will delve into the latest clinical evidence, exploring the benefits and applications of this dual therapy approach. This insightful session will provide actionable strategies for optimizing CRM patient outcomes, making it an essential event for healthcare professionals seeking to enhance their CRM practice.

CRM Legacy Meeting Unlocking Cardio-Renal-Metabolic Health: A Webinar on Empagliflozin-Linagliptin Combination

Chairman, Batra Heart Centre and Dean – Academics & Clinical Research, Batra Hospital and Medical Research Centre, New Delhi

This session brings together two leading cardiology experts to explore the critical challenge of hyperkalemia (HK) in heart failure management. The discussion will delve into the interplay between potassium levels, RAAS inhibitor therapy, and guideline-directed medical therapy (GDMT), highlighting how clinicians can balance treatment benefits with potassium management.

With a strong focus on real-world clinical decision-making, the session will cover practical strategies to identify and manage HK while supporting the continued use and optimization of life-saving heart failure therapies. It will also address common clinical challenges and considerations when HK becomes a potential barrier to achieving optimal GDMT.

Dr. Prof Upendra Kaul

3

438

7k

4.7

Upcoming Sessions

Sessions Taken

228

4.6

466

4.7